To hear about similar clinical trials, please enter your email below

Trial Title: Impact of Respiratory Training in Lymphoma Survivors

NCT ID: NCT05938127

Condition: Hodgkin Lymphoma
Non Hodgkin Lymphoma

Conditions: Official terms:
Lymphoma

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Basic Science

Masking: Single (Care Provider)

Intervention:

Intervention type: Device
Intervention name: Inspiratory muscle strength training
Description: High-resistance inspiratory muscle strength training (IMST) is a time-efficient (~5 minutes/day) form of exercise that employs an affordable, handheld device which impedes inspiratory breathing to train the diaphragm and accessory respiratory muscles
Arm group label: Lymphoma Survivors IMST

Other name: IMST

Intervention type: Device
Intervention name: Sham Inspiratory muscle strength training
Description: Low-resistance inspiratory muscle strength training
Arm group label: Lymphoma Survivors sham IMST

Other name: Sham IMST

Summary: High-resistance inspiratory muscle strength training (IMST) is a time-efficient (~5 minutes/day) form of exercise that employs an affordable, handheld device which impedes inspiratory breathing to train the diaphragm and accessory respiratory muscles and has demonstrated improvements in both cardiovascular health (9 mmHg reduction in systolic blood pressure, 45% improvement in vascular endothelial function) and improve exercise tolerance (12% increase in treadmill exercise time) in generally healthy midlife/older adults. Therefore, this approach may circumvent preventative hurdles to exercise, and augment the effects of exercise for capable survivors.

Detailed description: Cancer survivorship has been steadily improving as a result of earlier detection and improved therapies. Behind cancer recurrence, the primary cause of morbidity and mortality among survivors stems from the onset of cardiovascular disease that arises in part due to cardiotoxic chemo and radiation therapies. The increased risk of cardiovascular disease is particularly high in specific survivor populations, such as lymphoma survivors. Although exercise has been demonstrated to improve both recovery after cancer therapy and quality of life, both physical and logistical hurdles may prohibit certain patients from accessing this intervention. High-resistance inspiratory muscle strength training (IMST) is a time-efficient (~5 minutes/day) form of exercise that employs an affordable, handheld device which impedes inspiratory breathing to train the diaphragm and accessory respiratory muscles and has demonstrated improvements in both cardiovascular health (9 mmHg reduction in systolic blood pressure, 45% improvement in vascular endothelial function) and improve exercise tolerance (12% increase in treadmill exercise time) in generally healthy midlife/older adults. Therefore, this approach may circumvent preventative hurdles to exercise, and augment the effects of exercise for capable survivors.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Age 18 - 80 - Primary cancer diagnosis of lymphoma - Able and willing to participate in a supervised exercise program at the Anschutz Health and Wellness Center - Provides a signed physician exercise clearance form - SBP > 120 mmHg - Completion of curative cancer treatment over 12 months prior (individuals on maintenance therapy will be included) - Possession of a smartphone compatible with the IMST training application (available on both Android and Apple). Exclusion Criteria: - oSecond active cancer diagnosis - oPlanned active cancer treatment or change in current treatment in the next 6 months - Severe obesity (BMI > 40 kg/m2) or underweight (BMI < 18.5 kg/m2) - Unstable weight (> 3 kg change in body mass in last 3 months) - Significant metabolic disorder (e.g. diabetes type II) - Uncontrolled thyroid disease - Recent changes in hypertensive medication (within last 3 months) - Any medical condition that would impact the safety of, or participation in, an exercise program, including: - Significant pulmonary conditions such as chronic obstructive pulmonary disease, emphysema, or interstitial lung disease - Known cardiovascular disease, significant hypertension (> 180/120), or a recent cardiac event (within past 6 months) - Orthopedic conditions such as advanced osteoarthritis, mobility-limiting amputations or chronic injuries, or mobility-limiting acute orthopedic injuries - Advanced rheumatoid arthritis or chronic widespread pain conditions such as fibromyalgia

Gender: All

Minimum age: 18 Years

Maximum age: 80 Years

Healthy volunteers: No

Locations:

Facility:
Name: Anschutz Health and Wellness

Address:
City: Aurora
Zip: 80045
Country: United States

Status: Recruiting

Contact:
Last name: Jared Scorsone

Phone: 720-724-9601
Email: jared.scorsone@cuanschutz.edu

Contact backup:
Last name: Ryan J Marker, PT, PhD

Facility:
Name: University of Colorado Cancer Center

Address:
City: Aurora
Zip: 80045
Country: United States

Status: Recruiting

Contact:
Last name: Jared Scorsone

Phone: 7207249601
Email: jared.scorsone@cuanschutz.edu

Contact backup:
Last name: Ryan Marker, PT, PhD

Start date: December 2024

Completion date: January 2026

Lead sponsor:
Agency: University of Colorado, Denver
Agency class: Other

Source: University of Colorado, Denver

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05938127

Login to your account

Did you forget your password?